Polycystic ovary syndrome: menopause and malignancy

Authors

Karine Matevossian, Advocate Aurora HealthFollow
Olivia Carpinello

Recommended Citation

Matevossian K, Carpinello O. Polycystic Ovary Syndrome: Menopause and Malignancy. Clin Obstet Gynecol. 2021;64(1):102-109. doi:10.1097/GRF.0000000000000560

Affiliations

Advocate Aurora Lutheran General Hospital

Abstract

Polycystic ovary syndrome (PCOS) has been extensively studied in reproductive-aged women. However, accumulating research shows that PCOS can have lifelong effects on multiple aspects of women's health. PCOS can affect the onset and course of menopause and cardiovascular health in perimenopausal and postmenopausal patients. Moreover, PCOS may increase a woman's risk for both gynecologic and nongynecologic malignancies. When treating older PCOS patients, physicians should be cognizant of the syndrome's long-term effects and consider the unique needs of these women.

Document Type

Article

PubMed ID

32694295